Company Overview of Canaccord Genuity Limited
Canaccord Genuity Limited provides financial advisory services. It offers financial research, equity sales and trading, Employee Stock Option Programs (ESOP), and buyback services. Additionally, the firm provides investment banking services such as mergers and acquisitions advisory, underwriting, capital raising, valuation analysis, fairness opinions, private placements, divestitures, and Initial public Offerings (IPO). It caters to energy, technology, telecommunications, real estate, aerospace, and chemical industries. The firm was formerly known as Canaccord Adams Limited and changed it name to Canaccord Genuity Limited on May 10, 2010 after the acquisition of Genuity Capital Markets. Cana...
88 Wood Street
London, EC2V 7QR
Key Executives for Canaccord Genuity Limited
Chief Executive Officer and Director
President and President of Canadian Capital Markets Operations
Managing Director and Analyst
Compensation as of Fiscal Year 2014.
Canaccord Genuity Limited Key Developments
Canaccord Genuity Announces Executive Appointments
May 20 14
Canaccord Genuity announced two senior additions to the firm's US equity research group. Eli Kantor joins as a Managing Director based in the firm's Houston office with a focus on US Exploration & Production. Mr. Kantor joins Canaccord Genuity from Iberia Capital where he covered US Exploration & Production names with a focus on companies prominent in the Permian Basin. Noah Parquette joins as a Principal, covering Maritime Transportation companies and will work from the firm's US headquarters in New York. Prior to joining Canaccord Genuity, Mr. Parquette was a Senior Analyst at Maxim Capital, covering the US Shipping sector.
Hipcricket Engages Canaccord Genuity to Evaluate Strategic Alternatives
Feb 18 14
Hipcricket Inc. has retained the corporate advisory services of Canaccord Genuity to explore and evaluate strategic alternatives with a view to enhancing shareholder value. Hipcricket has not set a timetable for completion of the strategic review, and provides no assurance the process will result in a transaction or pursuit of any strategic alternative. The company will not comment further about the process until a specific transaction or direction is approved by the board of directors or the review process has been concluded, or it is otherwise determined that further disclosure is appropriate or required by law.
Silence Therapeutics plc Announces Appointment of Canaccord Genuity Limited as its Nominated Adviser and Broker
Nov 18 13
Silence Therapeutics plc announced the appointment of Canaccord Genuity Limited as the company's nominated adviser and broker with immediate effect.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries